Arkolith/Insider Trading/RVNC/Form 4

Kolaja Carey OConnor

DirectorRevance Therapeutics, Inc. (RVNC) · full profile →Form 4 · filed Jun 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$71K
Net Open-Market Flow
-$71K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2023Sell(S)3K$28.24$71K17K
Jun 15, 2023Option exercise(M)3K$18.12$45K19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2023Option exercise(M)3K—$08K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001479290-23-000080) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML